BRIGHT MINDS BIOSCIENCES INC. Revenue From Interest
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Revenue From Interest of CAD 30.13 thousand for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromInterest · last filed 2024-12-31
| Period end | Revenue From Interest 12 month |
|---|---|
| 2024-09-30 | 30.13K CAD 20-F · filed 2024-12-31 |
| 2023-09-30 | 0.00 CAD 20-F · filed 2024-12-31 |
| 2022-09-30 | 0.00 CAD 20-F · filed 2024-12-31 |